REG - Ocean Harvest Tech. - Strong Performance of OceanFeed in poultry trial

Ocean Harvest TechnologyAnnouncement

02/11/2023 07:16

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231102:nRSB1171Sa&default-theme=true

RNS Number : 1171S  Ocean Harvest Technology Group PLC  02 November 2023

2 November 2023

 

Ocean Harvest Technology Group plc

 

("OHT", the "Company", or the "Group")

 

Strong Performance of OceanFeed in poultry trial with necrotic enteritis
challenge

 

 

Ocean Harvest Technology Group Plc (AIM: OHT), a leading researcher, developer
and supplier of blended seaweed products as an additive for the global animal
feed industry, announces the results of a recent study designed to show the
effect of OceanFeed(TM) Poultry ("OFP") on performance in necrotic enteritis
("NE") challenged broilers or meat chickens.

 

The trial, which demonstrated encouraging results, was conducted at the
Southern Poultry Research Group in Georgia USA, which is globally recognised
as a leading poultry health and nutrition research institute.  A summary of
the trial results is below:

 

·      Sample size of 200 birds

·      Mortality reduced significantly from 49% to 33% (P<0.05) in
the group which had OceanFeed(TM) Poultry included in their diet

·      Enhanced weight gain and improved intestinal lesion scores in the
OceanFeed(TM) Poultry group

·      Data supports existing research on the ability of OceanFeed(TM)
to bind the pathogen Clostridium perfringens, the bacteria causing NE

 

Such data enhances the use case of OFP in the global poultry industry and will
be useful data in discussions with customers currently using and/or looking to
use OFP.

 

Market Opportunity:

The global poultry sector faces an annual cost of up to US$6bn from the impact
of NE, according to the Poultry Federation*. Necrotic enteritis is a disease
endemic to poultry, stemming from the overgrowth of the pathogen Clostridium
perfringens in the gut, which tends to increase in prominence with the reduced
usage of in feed antibiotics.  With consumer and regulatory pressure globally
to reduce or eliminate the use of antibiotics in animal production, helping
producers combat NE using a natural and sustainable feed ingredient is
increasingly important.

 

Mark Williams, CEO of OHT, commented:

 "We are very pleased to see these results.  We have previously released
trial data which demonstrates improved growth rates and feed conversion ratios
in broilers and improved egg production, egg quality and feed conversion in
laying hens with the dietary inclusion of OceanFeed(TM).  This new data shows
the additional benefits of significantly lower mortality in the presence of a
necrotic enteritis challenge, highlighting the greater potential commercial
advantages for customers using OceanFeed(TM) Poultry in their diets."

 

"This is another example of how the ongoing R&D program at OHT is
demonstrating multiple commercial and health benefits in numerous animal
species from the inclusion of OceanFeed(TM) in their diets."

 

*Source: BROOM, L. (2017). Necrotic enteritis; current knowledge and
diet-related mitigation. World's Poultry Science Journal, 73(2), 281-292.
doi:10.1017/S0043933917000058

 

 

For more information please contact:

 Ocean Harvest Technology Group plc                                  Tel: +44 (0)118 228 7612

 Mark Williams, CEO

 Cavendish Financial Ltd (Nominated Adviser and Sole Broker)         Tel: +44 020 7220 0500
 Geoff Nash / Seamus Fricker / George Dollemore (Corporate Finance)

 Charlotte Sutcliffe / Harriet Ward (ECM)

 Camarco (Financial PR Adviser)                                      Tel: +44 (0) 203 757 4991
 Tom Huddart / Rosie Driscoll / Letaba Rimell                        oht@camarco.co.uk (mailto:oht@camarco.co.uk)

 

 

 

 

Notes to Editors

 

Ocean Harvest Technology Group plc is a global leader in the development and
commercialisation of value adding products from multiple species of seaweed.
The Company provides a range of natural ingredients focused on improving
animal performance whilst protecting the environment, through its unique and
proven intellectual property portfolio. The Company's products are produced in
its facility in Vietnam from seaweeds soured from multiple markets across the
world.

For more information, please visit www.oceanharvesttechnology.com
(http://www.oceanharvesttechnology.com) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUPGGUGUPWPPG